Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 4.814\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) O=C(OCC(=O)c1ccc(Cl)s1)c1ccc(CO)cc1
(b) Br.COc1ccc2c(c1)nc(SCC(=O)c1ccc(Br)s1)n2C
(c) COc1ccc(NC2CCCN(C(=O)c3ccc4[nH]c(C)c(C)c4c3)C2)cc1OC
Answer: b. Br.COc1ccc2c(c1)nc(SCC(=O)c1ccc(Br)s1)n2C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Br.COc1ccc2c(c1)nc(SCC(=O)c1ccc(Br)s1)n2C
Br.COc1ccc2c(c1)nc(SCC(=O)c1ccc(Br)s1)n2C
1-(5-bromothiophen-2-yl)-2-(5-methoxy-1-methylbenzimidazol-2-yl)sulfanylethanone;hydrobromide